EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Willow Biosciences's enterprise value is C$13.75 Mil.
Willow Biosciences's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was C$0.95 Mil. Therefore, Willow Biosciences's EV-to-Revenue for today is 14.49.
The historical rank and industry rank for Willow Biosciences's EV-to-Revenue or its related term are showing as below:
TSX:WLLW'
s EV-to-Revenue Range Over the Past 10 Years
Min: -37.22 Med: 7.9 Max: 860.72
Current: 14.49
During the past 13 years, the highest EV-to-Revenue of Willow Biosciences was 860.72. The lowest was -37.22. And the median was 7.90.
TSX:WLLW's EV-to-Revenue is ranked worse than 90.38% of 1019
companies
in the Drug Manufacturers industry
Industry Median: 2.16
vs TSX:WLLW: 14.49
The historical data trend for Willow Biosciences's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Willow Biosciences's EV-to-Revenue
For the Drug Manufacturers - Specialty & Generic subindustry, Willow Biosciences's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Willow Biosciences's EV-to-Revenue Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Willow Biosciences's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Willow Biosciences's EV-to-Revenue falls into.
Willow Biosciences's current Enterprise Value is C$13.75 Mil.
Willow Biosciences's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.95 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Willow Biosciences's share price for today is C$0.105.
Willow Biosciences's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.01.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Willow Biosciences EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Willow Biosciences's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Willow Biosciences (TSX:WLLW) Business Description
Willow Biosciences Inc is a Canadian biotechnology company. It has only one reportable segment engaged in developing and producing high-purity, plant-derived ingredients for consumer care, food and beverage, and pharmaceutical products. Geographically, it derives a majority of its revenue from Canada.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TSX:WLLW has been successfully added to your 